Tim Loh Bloomberg
- All
- News
-
Covid Shots Targeting Delta May Be Needed, Researchers Say
Vaccines targeting the highly transmissible delta variant may now be needed, given its ability to infect people with fading immunity and potentially increased severity, researchers leading a large English study of Covid shots said.
-
As US, Others Fight Delta Fury, UK's Sudden Drop In Cases Brings Hope
Two weeks ago, the delta variant was ripping through the UK, stoking fears of a record wave of Covid-19 clobbering one of the world's most highly vaccinated countries.
-
AstraZeneca Blood Clot Worries Could Set Back Vaccinations Worldwide
Growing worries that AstraZeneca Plc's Covid-19 vaccine causes rare blood clots could hinder immunization campaigns across the world, from London to Seoul.
-
Scientists Create Antibody That Defeats Coronavirus in Lab: Report
Scientists created a monoclonal antibody that can defeat the new coronavirus in the lab, an early but promising step in efforts to find treatments and curb the pandemic's spread.
-
New Coronavirus Virus Test Shortens Wait From Two Days To 2.5 Hours
Robert Bosch GmbH became the latest company to roll out a Covid-19 test, saying it can diagnose in less than 2.5 hours and help efforts to fight the outbreak.
-
Basketball Star's Shoe Splits Seconds Into Play. Nike Looks For Answers
Nike is looking into what went wrong after college basketball's biggest star sprained his knee when his shoe fell apart, one of the most high-profile apparel failures in basketball history.
-
Hurting For Buyers, US Coal Miners Are Learning To Love India
The big bright spot for U.S. coal miners is located halfway around the world.
-
Once-Hot Material Graphene Could Be Next Battery Breakthrough
Remember graphene? The advanced material - made up of a lattice of carbon atoms - may be poised for a comeback, albeit a quiet one.
-
Covid Shots Targeting Delta May Be Needed, Researchers Say
Vaccines targeting the highly transmissible delta variant may now be needed, given its ability to infect people with fading immunity and potentially increased severity, researchers leading a large English study of Covid shots said.
-
As US, Others Fight Delta Fury, UK's Sudden Drop In Cases Brings Hope
Two weeks ago, the delta variant was ripping through the UK, stoking fears of a record wave of Covid-19 clobbering one of the world's most highly vaccinated countries.
-
AstraZeneca Blood Clot Worries Could Set Back Vaccinations Worldwide
Growing worries that AstraZeneca Plc's Covid-19 vaccine causes rare blood clots could hinder immunization campaigns across the world, from London to Seoul.
-
Scientists Create Antibody That Defeats Coronavirus in Lab: Report
Scientists created a monoclonal antibody that can defeat the new coronavirus in the lab, an early but promising step in efforts to find treatments and curb the pandemic's spread.
-
New Coronavirus Virus Test Shortens Wait From Two Days To 2.5 Hours
Robert Bosch GmbH became the latest company to roll out a Covid-19 test, saying it can diagnose in less than 2.5 hours and help efforts to fight the outbreak.
-
Basketball Star's Shoe Splits Seconds Into Play. Nike Looks For Answers
Nike is looking into what went wrong after college basketball's biggest star sprained his knee when his shoe fell apart, one of the most high-profile apparel failures in basketball history.
-
Hurting For Buyers, US Coal Miners Are Learning To Love India
The big bright spot for U.S. coal miners is located halfway around the world.
-
Once-Hot Material Graphene Could Be Next Battery Breakthrough
Remember graphene? The advanced material - made up of a lattice of carbon atoms - may be poised for a comeback, albeit a quiet one.
